Claybrook Capital’s Nu Skin NUS Stock Holding History

Claybrook Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$12K	–	487
2018 Q4	$12K	Buy	+200	New	+$13.5K	﹤0.01%	441

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Claybrook Capital's NUS Position: Q1 2019 in Review

Claybrook Capital sold out of Nu Skin (NUS) in Q1 2019, closing a stake of 200 shares — an estimated $12K sold.

Claybrook Capital first reported a position in NUS in Q4 2018 and held it in 1 quarter. The position peaked at $12K in Q4 2018. 277 funds tracked by Wall St. Rank hold NUS as of Q1 2019.

Claybrook Capital reported no remaining Nu Skin position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 200 Nu Skin shares in Q1 2019, an estimated $12K.
Claybrook Capital first reported a position in Nu Skin in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Nu Skin position peaked at $12K in Q4 2018.
277 funds tracked by Wall St. Rank held Nu Skin as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.